Sort
21,453 grants matching “tuberculosis”
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2015 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2016 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2012 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2014 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,553,502Sue Etkind · Ma St Executive Office Of Health & Human Services · U52 · FY2008 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,553,501Sue Etkind · Ma St Executive Office Of Health & Human Services · U52 · FY2009 · PS
Optimization Of HIV Specific Immune Responses In Vivo
$1,553,207Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
TUBERCULOSIS ELIMINATION
$1,552,963Wilfred Rabi · Tennessee State Department Of Health · U52 · FY2010 · PS
INTEGRINS AND MODULAR SURFACE PROTEINS IN VASCULATURE
$1,552,438Immune Disease Institute, Inc. · P01 · FY2000 · HL
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,551,986Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2022 · AI
Epidemiology and Impact of the HIV, NCD, and Urbanization Syndemic in Africa
$1,551,103Larry William Chang · Johns Hopkins University · R01 · FY2024 · HL
Human genetics of TB resistance in HIV-infected persons
$1,550,863Erwin Schurr · Mcgill University Health Ctr Res Inst · R01 · FY2020 · AI
VIRGINIA DEPT OF HEALTH, TUBERCULOSIS COOPERATIVE AGREEMENT
$1,550,712Kathryin Hafford · Virginia State Dept Of Health · U52 · FY2013 · PS
Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb
$1,549,810David Alland · Rbhs-New Jersey Medical School · R01 · FY2014 · AI
The Military HIV Research Program (MHRP) Clinical Trial Unit
$1,547,861Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2024 · AI
Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis
$1,546,239Kathlenn Kozar · Tulane University · N01 · FY2017 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,543,865Louisiana State Univ Hsc New Orleans · P01 · FY2004 · HL
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,543,843University Of Miami School Of Medicine · U01 · FY2000 · AI
TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study)
$1,543,781Payam Nahid · University Of California, San Francisco · R01 · FY2013 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,543,278Duke University · U01 · FY2004 · AI
ADULT AIDS CLINICAL TRIALS UNIT (ACTU)
$1,542,920University Of Southern California · U01 · FY2002 · AI
ABI Innovation: A framework to predictably manipulate a microbial gene regulatory program
$1,541,850Nitin Baliga · Institute For Systems Biology · · FY2016 · BIO
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,540,981University Of Miami School Of Medicine · U01 · FY2001 · AI
SAN DIEGO TUBERCULOSIS PREVENTION, CONTROL, TRAINING AND LAB
$1,540,508Kathleen Moser · County/San Diego Health / Human Ser/Ag · U52 · FY2013 · PS
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$1,540,000Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2013 · PS